Pharmacology of non-psychoactive phytocannabinoids and their potential for treatment of cardiometabolic disease.
(2025)
Book Chapter
WAINWRIGHT, C.L. and WALSH, S.K. 2025. Pharmacology of non-psychoactive phytocannabinoids and their potential for treatment of cardiometabolic disease. In Wainwright, C. and Schini-Kerth, V. (eds.) Natural products as sources of novel drugs. Handbook of experimental pharmacology, 287. Cham: Springer [online], pages 61-93. Available from: https://doi.org/10.1007/164_2024_731
The use of Cannabis sativa by humans dates back to the third millennium BC, and it has been utilized in many forms for multiple purposes, including production of fibre and rope, as food and medicine, and (perhaps most notably) for its psychoactive pr... Read More about Pharmacology of non-psychoactive phytocannabinoids and their potential for treatment of cardiometabolic disease..